Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
PUT
PayPal
PYPL
$50.8B
| $15.6M | ﹤0.01% |
+200,000
| New | +$13.4M |
|
|
ENLC
1202
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $15.6M | ﹤0.01% |
1,073,978
+31,414
| +3% | +$432K |
|
1203
Omega Healthcare
OHI
$14.7B
| $15.6M | ﹤0.01% |
382,507
-145,566
| -28% | -$5.51M |
|
1204
iRhythm Holdings
IRTC
$4.28B
| $15.5M | ﹤0.01% |
209,247
+53,498
| +34% | +$4.26M |
|
1205
Check Point Software Technologies
CHKP
$12.9B
| $15.5M | ﹤0.01% |
80,432
+4,522
| +6% | +$828K |
|
1206
PUT
Alnylam Pharmaceuticals
ALNY
$28.8B
| $15.5M | ﹤0.01% |
+56,300
| New | +$14.7M |
|
1207
PUT
S&P Global
SPGI
$121B
| $15.4M | ﹤0.01% |
+29,900
| New | +$14.8M |
|
1208
Li Auto
LI
$12.8B
| $15.4M | ﹤0.01% |
602,028
+192,414
| +47% | +$3.91M |
|
|
GAP
1209
CALL
The Gap Inc
GAP
$7.43B
| $15.4M | ﹤0.01% |
700,000
-75,000
| -10% | -$1.67M |
|
1210
The Ensign Group
ENSG
$10.6B
| $15.4M | ﹤0.01% |
107,288
+77,514
| +260% | +$11M |
|
1211
Bath & Body Works
BBWI
$4.11B
| $15.4M | ﹤0.01% |
481,490
-108,070
| -18% | -$3.58M |
|
1212
CALL
Philip Morris
PM
$296B
| $15.3M | ﹤0.01% |
126,400
-436,700
| -78% | -$50.7M |
|
1213
Ally Financial
ALLY
$13.3B
| $15.3M | ﹤0.01% |
431,120
+113,270
| +36% | +$4.53M |
|
1214
Crown Holdings
CCK
$13.1B
| $15.3M | ﹤0.01% |
159,686
-174,122
| -52% | -$15M |
|
1215
Plains GP Holdings
PAGP
$4.93B
| $15.3M | ﹤0.01% |
825,497
-45,199
| -5% | -$858K |
|
1216
Federal Realty Investment Trust
FRT
$10.3B
| $15.2M | ﹤0.01% |
132,497
+4,324
| +3% | +$483K |
|
1217
Knife River
KNF
$3.79B
| $15.2M | ﹤0.01% |
170,101
+103,713
| +156% | +$8.1M |
|
1218
CALL
Affirm
AFRM
$25.8B
| $15.1M | ﹤0.01% |
370,000
+300,000
| +429% | +$9.95M |
|
|
CYBR
1219
DELISTED
CyberArk
CYBR
| $15.1M | ﹤0.01% |
51,750
-119,755
| -70% | -$32.4M |
|
1220
Middleby
MIDD
$6.06B
| $15.1M | ﹤0.01% |
108,429
+13,587
| +14% | +$1.83M |
|
1221
Corcept Therapeutics
CORT
$11.8B
| $15.1M | ﹤0.01% |
325,953
+61,510
| +23% | +$2.19M |
|
1222
Matsons
MATX
$6.19B
| $15M | ﹤0.01% |
105,360
-6,307
| -6% | -$830K |
|
|
JBTM
1223
JBT Marel
JBTM
$6.5B
| $15M | ﹤0.01% |
152,509
+10,236
| +7% | +$945K |
|
1224
CALL
Boston Scientific
BSX
$72B
| $15M | ﹤0.01% |
178,700
-802,400
| -82% | -$63.3M |
|
1225
Omnicell
OMCL
$1.68B
| $14.8M | ﹤0.01% |
339,536
+122,001
| +56% | +$4.6M |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.